Deferring Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Non-Small Cell Lung Cancer: A Multi-Institutional Analysis

被引：1
|
作者：
Magnuson, W. J. [1 ]
Amini, A. [2 ]
Patil, T. [3 ]
Kavanagh, B. D. [2 ]
Camidge, D. R. [4 ]
Braunstein, S. E. [5 ]
Boreta, L. [5 ]
Attia, A. [6 ]
Rana, N. [6 ]
Contessa, J. N. [1 ]
Gettinger, S. N. [7 ]
Lester-Coll, N. H. [1 ]
Yu, J. B. [8 ]
Chiang, V. L. [9 ]
机构：
[1] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA
[2] Univ Colorado Denver, Dept Radiat Oncol, Aurora, CO USA
[3] Univ Colorado, Dept Internal Med, Denver, CO 80202 USA
[4] Univ Colorado, Dept Med Oncol, Denver, CO 80202 USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
[6] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN USA
[7] Yale Univ, Dept Med Oncol, New Haven, CT USA
[8] Yale Sch Med, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA
[9] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
128
引用
收藏
页码：S57 / S58
页数：2
相关论文
共 50 条
  • [21] The Effectiveness of Afatinib as First-Line Treatment in Vietnamese Patients With EGFR-Mutant Non-Small Cell Lung Cancer and Brain Metastases
    Van Pham, Thai
    Vu, Thanh Ha
    Nguyen, Hoa Thai Thi
    Pham, Phuong Cam
    Do, Anh Tu
    Nguyen, Tuan Khoi
    Hoang, Thi Anh Thu
    Le, Tuan Anh
    Vuong, Dinh Thy Hao
    Nguyen, Dac Nhan Tam
    Dang, Van Khiem
    Nguyen, Thi Oanh
    Pham, Van Luan
    Nguyen, Minh Hai
    Vo, Thi Huyen Trang
    Mai, Khoa Trong
    Do, Hung Kien
    Nguyen, Thi Thuy Hang
    Trinh, Le Huy
    Nguyen, Hoang Gia
    Truong, Cong Minh
    Pham, Tran Minh Chau
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024,
  • [22] Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer
    Tozuka, Takehiro
    Noro, Rintaro
    Mizutani, Hideaki
    Kurimoto, Futoshi
    Hakozaki, Taiki
    Hisakane, Kakeru
    Naito, Tomoyuki
    Takahashi, Satoshi
    Taniuchi, Namiko
    Yajima, Chika
    Hosomi, Yukio
    Hirose, Takashi
    Minegishi, Yuji
    Okano, Tetsuya
    Kamio, Koichiro
    Yamaguchi, Tomoyoshi
    Seike, Masahiro
    LUNG CANCER, 2024, 191
  • [23] ERLOTINIB VERSUS RADIATION THERAPY FOR BRAIN METASTASES IN PATIENTS WITH EGFR-MUTANT LUNG ADENOCARCINOMA
    Gerber, Naamit K.
    Yamada, Yoshiya
    Shi, Weiji
    Zhang, Zhigang
    Riely, Gregory
    Beal, Kathryn
    Yu, Helena A.
    Chan, Timothy A.
    Rimner, Andreas
    Wu, Abraham J.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S902 - S902
  • [24] Comparative analysis of first-line treatment regimens for advanced EGFR-mutant non-small cell lung cancer patients with stable brain metastases
    Dai, Lu
    Luo, Chun-Yue
    Hu, Guang-Xia
    Chen, Gang
    Wu, Chuan-Xin
    Yin, Jun
    Jiang, Ze-Yong
    Hu, Guang-Fu
    Zhao, Jian
    Fu, Wen-Fan
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (04) : 2062 - +
  • [25] Erlotinib Versus Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Lung Adenocarcinoma
    Gerber, Naamit K.
    Yamada, Yoshiya
    Rimner, Andreas
    Shi, Weiji
    Riely, Gregory J.
    Beal, Kathryn
    Yu, Helena A.
    Chan, Timothy A.
    Zhang, Zhigang
    Wu, Abraham J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (02): : 322 - 329
  • [26] Prognostic value of EGFR genotype in EGFR-mutant non-small cell lung cancer
    Syrigos, Konstantinos
    Kotteas, Ilias
    Paraskeva, Maria
    Gkiozos, Ioannis
    Boura, Paraskevi
    Tsagouli, Sofia
    Grapsa, Dimitra
    Charpidou, Andriani
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [27] Osimertinib for EGFR-mutant non-small cell lung cancer: place in therapy and future perspectives
    Ricciuti, Biagio
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S249 - S252
  • [28] Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis
    Wen, Lei
    Zhen, Junjie
    Shan, Changguo
    Lai, Mingyao
    Hong, Weiping
    Wang, Hui
    Ye, Mingting
    Yang, Yanying
    Li, Shaoqun
    Zhou, Zhaoming
    Zhou, Jiangfen
    Hu, Qingjun
    Li, Juan
    Tian, Xuwei
    Chen, Longhua
    Cai, Linbo
    Xie, Zhanhong
    Zhou, Cheng
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [29] Impact of sequential therapy with osimertinib on the overall survival in patients with EGFR-mutant non-small cell lung cancer
    Inomata, Minehiko
    Matsumoto, Masahiro
    Mizushima, Isami
    Hayashi, Kana
    Seto, Zenta
    Tokui, Kotaro
    Taka, Chihiro
    Okazawa, Seisuke
    Kambara, Kenta
    Imanishi, Shingo
    Miwa, Toshiro
    Hayashi, Ryuji
    Matsui, Shoko
    Tobe, Kazuyuki
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2022, 16 (01)
  • [30] Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis
    Lei Wen
    Junjie Zhen
    Changguo Shan
    Mingyao Lai
    Weiping Hong
    Hui Wang
    Mingting Ye
    Yanying Yang
    Shaoqun Li
    Zhaoming Zhou
    Jiangfen Zhou
    Qingjun Hu
    Juan Li
    Xuwei Tian
    Longhua Chen
    Linbo Cai
    Zhanhong Xie
    Cheng Zhou
    European Journal of Medical Research, 28
12345